Plasma prostaglandins in hypercalcemic patients with neoplastic disease

Laurence Demers, J. C. Allegra, Harold Harvey, Allan Lipton, J. R. Luderer, R. Mortel, D. E. Brenner

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

Peripheral plasma prostaglandin E (PGE) determinations were performed on a series of 79 patients with solid tumor neoplasms and correlated with their serum calcium levels. Fourteen patients were hypercalcemic and 11 of these had significant elevations in circulating plasma PGE. Ten of the hypercalcemic group had extensive metastases to bone. These findings support the recently developed hypothesis that prostaglandins are causally related to the genesis of hypercalcemia in malignancy.

Original languageEnglish (US)
Pages (from-to)1559-1562
Number of pages4
JournalCancer
Volume39
Issue number4
DOIs
StatePublished - Jan 1 1977

Fingerprint

Prostaglandins
Prostaglandins E
Neoplasms
Hypercalcemia
Neoplasm Metastasis
Calcium
Bone and Bones
Serum

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Demers, Laurence ; Allegra, J. C. ; Harvey, Harold ; Lipton, Allan ; Luderer, J. R. ; Mortel, R. ; Brenner, D. E. / Plasma prostaglandins in hypercalcemic patients with neoplastic disease. In: Cancer. 1977 ; Vol. 39, No. 4. pp. 1559-1562.
@article{9964674f8e58403c9db766f182706a97,
title = "Plasma prostaglandins in hypercalcemic patients with neoplastic disease",
abstract = "Peripheral plasma prostaglandin E (PGE) determinations were performed on a series of 79 patients with solid tumor neoplasms and correlated with their serum calcium levels. Fourteen patients were hypercalcemic and 11 of these had significant elevations in circulating plasma PGE. Ten of the hypercalcemic group had extensive metastases to bone. These findings support the recently developed hypothesis that prostaglandins are causally related to the genesis of hypercalcemia in malignancy.",
author = "Laurence Demers and Allegra, {J. C.} and Harold Harvey and Allan Lipton and Luderer, {J. R.} and R. Mortel and Brenner, {D. E.}",
year = "1977",
month = "1",
day = "1",
doi = "10.1002/1097-0142(197704)39:4<1559::AID-CNCR2820390430>3.0.CO;2-3",
language = "English (US)",
volume = "39",
pages = "1559--1562",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

Plasma prostaglandins in hypercalcemic patients with neoplastic disease. / Demers, Laurence; Allegra, J. C.; Harvey, Harold; Lipton, Allan; Luderer, J. R.; Mortel, R.; Brenner, D. E.

In: Cancer, Vol. 39, No. 4, 01.01.1977, p. 1559-1562.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Plasma prostaglandins in hypercalcemic patients with neoplastic disease

AU - Demers, Laurence

AU - Allegra, J. C.

AU - Harvey, Harold

AU - Lipton, Allan

AU - Luderer, J. R.

AU - Mortel, R.

AU - Brenner, D. E.

PY - 1977/1/1

Y1 - 1977/1/1

N2 - Peripheral plasma prostaglandin E (PGE) determinations were performed on a series of 79 patients with solid tumor neoplasms and correlated with their serum calcium levels. Fourteen patients were hypercalcemic and 11 of these had significant elevations in circulating plasma PGE. Ten of the hypercalcemic group had extensive metastases to bone. These findings support the recently developed hypothesis that prostaglandins are causally related to the genesis of hypercalcemia in malignancy.

AB - Peripheral plasma prostaglandin E (PGE) determinations were performed on a series of 79 patients with solid tumor neoplasms and correlated with their serum calcium levels. Fourteen patients were hypercalcemic and 11 of these had significant elevations in circulating plasma PGE. Ten of the hypercalcemic group had extensive metastases to bone. These findings support the recently developed hypothesis that prostaglandins are causally related to the genesis of hypercalcemia in malignancy.

UR - http://www.scopus.com/inward/record.url?scp=0017654073&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017654073&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(197704)39:4<1559::AID-CNCR2820390430>3.0.CO;2-3

DO - 10.1002/1097-0142(197704)39:4<1559::AID-CNCR2820390430>3.0.CO;2-3

M3 - Article

VL - 39

SP - 1559

EP - 1562

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 4

ER -